1. Home
  2. Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy

Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy

All data supporting the publication "Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy"

    Organizational unit
    Transplantation and Hepatology Laboratory
    Type
    Dataset
    DOI
    License
    Creative Commons Attribution 4.0 International
    Keywords
    immune checkpoint inhibitor, hepatocellular carcinoma, hepatectomy, neoadjuvant, adjuvant, myeloid-derived suppressor cells
Publication date01/09/2025
Retention date30/08/2035
accessLevelPublicAccess levelPublic
SensitivityBlue
licenseContract on the use of data
License
Contributors
  • Lacotte, Stéphanie orcid
  • TOSO, Christian
5
1
  • Quality (0 Reviews)
  • Usefulness (0 Reviews)

Datacite metadata

Packages information

Similar archives

Transplantation and Hepatology Laboratory
Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models
2022 accessLevelPublic Public 75.4 GB
Transplantation and Hepatology Laboratory
FGF21 negatively affects long-term female fertility in mice
2022 accessLevelPublic Public 1.6 GB
Transplantation and Hepatology Laboratory
Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models (2)
2023 accessLevelPublic Public 8.7 GB
Transplantation and Hepatology Laboratory
Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models (3)
2023 accessLevelPublic Public 10.7 GB
All rights reserved by DLCM and the University of GenevaunigeBlack